IMMUNE THROMBOCYTOPENIC PURPURA AS A PREDECESSOR OF GLIOBLASTOMA MULTIFORME
DOI:
https://doi.org/10.52428/20756208.v17i42.224Keywords:
Glioblastoma, Purpura, Thrombocytopenia, AutoimmuneAbstract
The clinical case presented below is that of a 68-year-old female patient with a history of long-standing type 2 diabetes mellitus, who presented clinical symptoms characterized by aphasia, apraxia, and facio-brachio-crural hemiparesis on several occasions. These symptoms were attributed to subarachnoid hemorrhage due to severe thrombocytopenia. For this she was diagnosed with Immune Thrombocytopenic Purpura. She was hospitalized on several occasions during which complementary studies were carried out. These studies helped us diagnosed an autoimmune hepatitis. In her last hospitalization for the same condition, a simple cerebral computed tomography was performed due to the already known history of subarachnoid hemorrhage in which a lesion compatible with a solid mass was evidenced. The study of the tumor was completed with a magnetic resonance image (MRI) contrasted with gadolinium. In the MRI we observed an infiltrative tumor mass highly suggestive of a high-grade glial tumor (Multiform glioblastoma). Due to the characteristics of the patient´s underlying diseases and family decision, no treatment was carried out. This led to a decline in the general condition of the patient, culminating in her death.
Downloads
References
Cooper N. Immune Thrombocytopenia. The New England Journal of Medicine. 2019; X(381). Doi: https://doi.org/10.1056/NEJMcp1810479 DOI: https://doi.org/10.1056/NEJMcp1810479
Rodríguez W. Fisiología plaquetaria, agregometría plaquetaria y su utilidad clinica. Med Int Méx. 2018; 34(244-263). Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2018/mim182g.pdf
Michael H. Normal Platelet Function. US National Library of Medicine Institutes of Health. 2017; 36(195-198). Doi: https://doi.org/10.1007/s10555-017-9677-x DOI: https://doi.org/10.1007/s10555-017-9677-x
Michelson A. Platelets. Cuarta ed. ALAN D. MICHELSON M, editor. Londres: Elsevier Inc.; 2019. Disponible en: https://www.elsevier.com/books/platelets/michelson/978-0-12-813456-6
Cindy N. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Ashpublications. 2011; 117(16). Doi: https://doi.org/10.1182/blood-2010-08-302984 DOI: https://doi.org/10.1182/blood-2010-08-302984
Drew P. International consensus report on the investigation and management of primary immune thrombocytopenia. Ashpublications. 2019; 115(2). Doi: https://doi.org/10.51581/rccm.v22i2.14
Nelson G. Púrpura Trombocitopénica Idiopatica en Adultos: Experiencia en un Hospital de Tercer nivel, La Paz, Bolivia. Scielo. 2019; 22(2). Disponible en: https://doi.org/10.1182/bloodadvances.2019000812
Alena Horská. Imaging of Brain Tumors: MR Spectroscopy and Metabolic Imaging. National Library of Medicine. 2010; 20(293-310). Doi: https://doi.org/10.51581/rccm.v22i2.14 DOI: https://doi.org/10.1016/j.nic.2010.04.003
Khasraw M. Trombocytopenia in Solid Tumors. European Journal of Clinical & Medical Oncology. 2010; 2(2). Doi: https://doi.org/10.51581/rccm.v22i2.14 DOI: https://doi.org/10.51581/rccm.v22i2.14
Ito A. Autoinmune Hepatitis Associated with Inmune Thrombocytopenic Purpura. Internal Medicine. 2017; 56(143-147). Doi: https://doi.org/10.2169/internalmedicine.56.7506 DOI: https://doi.org/10.2169/internalmedicine.56.7506
Francis K. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura. Oncologist. 2007; 12(11-19). Doi: https://doi.org/10.1634/theoncologist.12-1-11 DOI: https://doi.org/10.1634/theoncologist.12-1-11
Ekstrand C. Cancer risk in patients with primari inmune thrombocytopenia - A Swedish nationwide register study. Elsevier. 2020; 69. Doi: https://doi.org/10.1634/theoncologist.12-1-11 DOI: https://doi.org/10.1016/j.canep.2020.101806
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Nicolas Rojas Stambuk, Ivanova Saavedra Tapia
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License 4.0 that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
